Patent · US Active

Compositions and methods for inhibition of the JAK pathway

US9566283B2 · kind B2 · utility

2Cited by
10References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2015
Grant dateFeb 14, 2017
Priority date
Expiry dateJul 7, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65583
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.